Companion Animal Postoperative Pain Management Therapeutics Market to see Huge Growth by 2029
Companion animal postoperative pain management therapeutics market is expected to grow at a significant CAGR during the forecast period. The demand for postoperative pain relievers is increasing as the number of pet surgical operations, particularly orthopaedic and dental surgery, increases. The rising frequency of periodontal disease is likely to drive the demand for dental procedures. According to the AMA research, dog clinic visits climbed by 6% from 2014 to 2017, owing to an increase in dental disorders. Revenue growth is expected to be aided by rising companion animal ownership. The market is likely to be fueled by increased acceptance of NSAIDs coupled with the restricted use of opioids to reduce postoperative pain. The demand for companion pain-relieving medications is expected to rise significantly owing to rising concerns among pet owners and decreased use of off-label human painkillers. The unmet demand for long-acting local anaesthetics in small animals is motivating the pharmaceutical sector to create these medications.
For instance, in situ Biologics', AniGel SR
demonstrated 72-hour efficacy in pre-clinical research for postoperative pain
management. The medicine is awaiting approval from the US Food and Drug
Administration (FDA), which would likely raise market revenue in the future
years. The Animal Cancer Foundation estimates that there were 65 million dogs
and 32 million cats in the US in 2017. The market for companion animal
postoperative pain management pharmaceuticals is being fueled by an increase in
the number of veterinary facilities and pet clinics. According to a survey by
the American Veterinary Medical Association (AVMA), private practise for small
animals increased by 14% in the United States in 2018. Opioids' use as
postoperative pain medications is being hampered by strict rules on their use
in people and animals. Around 40% of veterinarians in the US prescribed opioids
for perioperative therapy in animals in 2014. These factors are projected to
hinder the growth of the market.
To Request a Sample of our Report on Companion Animal
Postoperative Pain Management Therapeutics Market: https://www.omrglobal.com/request-sample/companion-animal-postoperative-pain-management-therapeutics-market
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Zoetis
Inc., Merck Animal Health, and Ceva Santé Animale, among Others.
Companion Animal Postoperative Pain Management Therapeutics Market Report
Segmentation
By Product
• NSAIDs
• Anesthetics
• Others
By Animal Type
• Canine
• Feline
A
full Report of Companion Animal Postoperative Pain Management Therapeutics
Market is Available at: https://www.omrglobal.com/industry-reports/companion-animal-postoperative-pain-management-therapeutics-market
Companion Animal Postoperative Pain Management Therapeutics Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment